Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) has announced an interim ordinary dividend of RMB 1 for every 10 shares, equivalent to RMB 0.10 per share, for the six months ended 30 June 2026. The dividend, pertaining to the financial year ending 31 December 2026, was approved by shareholders on 25 June 2026 and disclosed on 28 August 2026.

Key distribution details—including the default payment currency, applicable exchange rate for Hong Kong-listed H shares, ex-dividend date, record date, and payment date—will be confirmed in a subsequent notice. Withholding-tax arrangements are also pending disclosure. Tricor Investor Services Limited will act as the Hong Kong share registrar for processing share transfers tied to dividend entitlement.

At the time of the announcement, SH PHARMA’s board comprises four executive directors (Yang Qiuhua, Shen Bo, Li Yongzhong, Dong Ming), one non-executive director (Zhang Wenxue), one employee representative director (Zhao Yong), and four independent non-executive directors (Wang Zhong, Man Kwan, Xue Yunkui, Wang Qian).

All other terms, including any implications for listed warrants or convertible securities, are marked as not applicable in the filing.